489 Mullin, C.M., M.A. Arkans, C.D. Sammarco, et al. 2016. Doxorubicin chemotherapy for presumptive cardiac hemangiosarcoma in dogs(dagger). Vet Comp Oncol 14:e171–e183.
490 Mullins, M.N., W.S. Dernell, S.J. Withrow, et al. 2006. Evaluation of prognostic factors associated with outcome in dogs with multiple cutaneous mast cell tumors treated with surgery with and without adjuvant treatment: 54 cases (1998–2004). J Am Vet Med Assoc 228:91–95.
491 Muraro, L., F. Aprea, and R.A. White. 2013. Successful management of an arytenoid chondrosarcoma in a dog. J Small Anim Pract 54:33–35.
492 Murphy, S., A. Gutierrez, J. Lawrence, et al. 2008. Laparoscopically implanted tissue expander radiotherapy in canine transitional cell carcinoma. Vet Radiol Ultrasound 49:400–405.
493 Murphy, S., A.M. Hayes, L. Blackwood, et al. 2005. Oral malignant melanoma ‐ the effect of coarse fractionation radiotherapy alone or with adjuvant carboplatin therapy. Vet Comp Oncol 3:222–229.
494 Murphy, S., A.H. Sparkes, A.S. Blunden, et al. 2006. Effects of stage and number of tumours on prognosis of dogs with cutaneous mast cell tumours. Vet Rec 158:287–291.
495 Murphy, S., A.H. Sparkes, K.C. Smith, et al. 2004. Relationships between the histological grade of cutaneous mast cell tumours in dogs, their survival and the efficacy of surgical resection. Vet Rec 154:743–746.
496 Mutsaers, A.J. 2009. Metronomic chemotherapy. Top Companion Anim Med 24:137–143.
497 Mutsaers, A.J., N.W. Glickman, D.B. Denicola, et al. 2002. Evaluation of treatment with doxorubicin and piroxicam or doxorubicin alone for multicentric lymphoma in dogs. J Am Vet Med Assoc 220:1813–1817.
498 Myers, N.C., 3rd, A.S. Moore, W.M. Rand, et al. 1997. Evaluation of a multidrug chemotherapy protocol (Acopa II) in dogs with lymphoma. J Vet Intern Med 11:333–339.
499 Naan, E.C., J. Kirpensteijn, H.S. Kooistra, et al. 2006. Results of thyroidectomy in 101 cats with hyperthyroidism. Vet Surg 35:287–293.
500 Nadeau, M.E. and B.E. Kitchell. 2011. Evaluation of the use of chemotherapy and other prognostic variables for surgically excised canine thyroid carcinoma with and without metastasis. Can Vet J 52:994–998.
501 Nadeau, M.E., B.E. Kitchell, R.L. Rooks, et al. 2004. Cobalt radiation with or without low‐dose cisplatin for treatment of canine naso‐sinus carcinomas. Vet Radiol Ultrasound 45:362–367.
502 Newcombe, J. and M. Chir. 1966. Effect of intra‐arterial nitrogen mustard infusion on wound healing in rabbits: formation of granulation tissue and wound contraction. Ann Surg 163(3):319–329.
503 Nieset, J.R., J.F. Harmon, T.E. Johnson, et al. 2014. Comparison of adaptive radiotherapy techniques for external radiation therapy of canine bladder cancer. Vet Radiol Ultrasound 55:644–650.
504 Nishioko, Y., S. Kyotani, M. Okamura, et al. 1992. A study of embolizing materials for chemo‐embolisation therapy of hepatocellular carcinoma: Embolic effect of cisplatin albumin microspheres using chitin and chitosan in dogs, and changes of cisplatin content in blood and tissue. Chem Pharm Bull (Tokyo) 40:267–268.
505 Nolan, M.W., L. Kogan, L.R. Griffin, et al. 2012. Intensity‐modulated and image‐guided radiation therapy for treatment of genitourinary carcinomas in dogs. J Vet Intern Med 26:987–995.
506 Norris, A.M., E.J. Laing, V.E.O. Valli, et al. 1992. Canine bladder and urethral tumors: A retrospective study of 115 cases (1980–1985). J Vet Intern Med 6:145–153.
507 Northrup, N.C., S.M. Etue, D.M. Ruslander, et al. 2001. Retrospective study of orthovoltage radiation therapy for nasal tumors in 42 dogs. J Vet Intern Med 15:183–189.
508 Northrup, N.C., T.L. Gieger, C.E. Kosarek, et al. 2009. Mechlorethamine, procarbazine and prednisone for the treatment of resistant lymphoma in dogs. Vet Comp Oncol 7:38–44.
509 Northrup, N.C., K.M. Rassnick, T.L. Gieger, et al. 2013. Prospective evaluation of biweekly streptozotocin in 19 dogs with insulinoma. J Vet Intern Med 27:483–490.
510 Novosad, C.A., P.J. Bergman, M.G. O’Brien, et al. 2006. Retrospective evaluation of adjunctive doxorubicin for the treatment of feline mammary gland adenocarcinoma: 67 cases. J Am Anim Hosp Assoc 42:110–120.
511 Nucci, D.J., J.M. Liptak, L.E. Selmic, et al. 2014. Complications and outcomes following rectal pull‐through surgery in dogs with rectal masses: 74 cases (2000–2013). J Am Vet Med Assoc 245:684–695.
512 O’Brien, M.G., S.J. Withrow, and R.C. Straw. 1996. Limb‐sparing surgery versus amputation for dogs with bone tumors. Vet Clin North Am Small Anim Pract 26:135–143.
513 Oblak, M.L., S.E. Boston, G. Higginson, et al. 2012. The impact of pamidronate and chemotherapy on survival times in dogs with appendicular primary bone tumors treated with palliative radiation therapy. Vet Surg 41:430–435.
514 O’Connell, K. and M. Thomson. 2013. Evaluation of prognostic indicators in dogs with multiple, simultaneously occurring cutaneous mast cell tumours: 63 cases. Vet Comp Oncol 11:51–62.
515 O’Connor, C.M., S. Sheppard, C.A. Hartline, et al. 2012. Adoptive T‐cell therapy improves treatment of canine non‐Hodgkin lymphoma post chemotherapy. Sci Rep 2:249.
516 O’Connor, C.M. and H. Wilson‐Robles. 2014. Developing T cell cancer immunotherapy in the dog with lymphoma. ILAR J 55:169–181.
517 Ogilvie, G.K., J.E. Obradovich, R.E. Elmslie, et al. 1991. Efficacy of mitoxantrone against various neoplasms in dogs. J Am Vet Med Assoc 198:1618–1621.
518 Ogilvie, G.K., B.E. Powers, C.H. Mallinckrodt, et al. 1996. Surgery and doxorubicin in dogs with hemangiosarcoma. J Vet Intern Med 10:379–384.
519 Olsen, J., J. Komtebedde, A. Lackner, et al. 1994. Cytoreductive treatment of ovarian carcinoma in a dog. J Vet Intern Med 8:133–135.
520 Osborne, C.A., V. Perman, J.H. Sautter, et al. 1968. Multiple myeloma in the dog. J Am Vet Med Assoc 153:1300–1319.
521 O’Sullivan, B., A.M. Davis, R. Turcotte, et al. 2002. Preoperative versus postoperative radiotherapy in soft‐tissue sarcoma of the limbs: A randomised trial. Lancet 359:2235–2241.
522 O’Sullivan, B., P. Gullane, J. Irish, et al. 2003. Preoperative radiotherapy for adult head and neck soft tissue sarcoma: Assessment of wound complication rates and cancer outcome in a prospective series. World J Surg 27:875–883.
523 Ottnod, J.M., R.C. Smedley, R. Walshaw, et al. 2013. A retrospective analysis of the efficacy of Oncept vaccine for the adjunct treatment of canine oral malignant melanoma. Vet Comp Oncol 11:219–229.
524 Overly, B., M. Goldschmidt, F. Schofer, et al. 2001. Canine oral melanoma: A retrospective study. Vet Cancer Soc Proc 21:43.
525 Pack, L., R.E. Roberts, S.D. Dawson, et al. 2001. Definitive radiation therapy for infiltrative thyroid carcinoma in dogs. Vet Radiol Ultrasound 42:471–474.
526 Padgett, S. 2002. Feline thyroid surgery. Vet Clin North Am Small Anim Pract 32:851–859, vi.
527 Page, R.L., D.W. Macy, G.K. Ogilvie, et al. 1992. Phase Iii evaluation of doxorubicin and whole‐body hyperthermia in dogs with lymphoma. Int J Hyperthermia 8:187–197.
528 Page, R.L., D.E. Thrall, M.W. Dewhirst, et al. 1991. Phase I study of melphalan alone and melphalan plus whole body hyperthermia in dogs with malignant melanoma. Int J Hyperthermia 7:559–566.
529 Panciera, D.L., O.I. Lanz, and D.M. Vail. 2004. Treating thyroid and parathyroid neoplasia in dogs and cats. Vet Med 99:154.
530 Paoloni, M.C., D.G. Penninck, and A.S. Moore. 2002. Ultrasonographic and clinicopathologic findings in 21 dogs with intestinal adenocarcinoma. Vet Radiol Ultrasound 43:562–567.
531 Patnaik, A.K., W.J. Ehler, and E.G. MacEwen. 1984. Canine cutaneous mast cell tumor: Morphologic grading and survival time in 83 dogs. Vet Pathol 21:469–474.
532 Patnaik, A.K., S.K.